Archives
Mithramycin A: DNA-Targeted Assay Workflows
2026-09-08
Mithramycin A turns metal-dependent recognition of G-C-rich DNA into a practical perturbation tool for transcription, c-myc regulation, and myeloid differentiation. This workflow-focused guide also shows how to evaluate its hypothesis-generating use alongside the miR-24-3p/Sp1/PI3K findings in cardiac injury research without mistaking a broad transcriptional probe for a pathway-specific inhibitor.
Hepatic sEH, Nrf2, and Osteoclastogenesis
2026-09-08
A recent Free Radical Biology and Medicine study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating epoxyeicosatrienoic acid metabolites and suppresses Nrf2–ARE signaling during osteoporosis. Clinical samples, ovariectomized mice, liver-specific knockdown, pharmacological inhibition, and osteoclast cultures collectively connect redox imbalance with osteoclast differentiation, while also defining important limits for translation to other research settings.
Drug Response Metrics for Cancer In Vitro Studies
2026-09-07
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer response. Its central contribution is a framework for separating growth inhibition from cell killing while considering their different proportions and temporal behavior, with direct implications for evaluating DNA methyltransferase inhibitors and other cancer therapies.
S Tag Peptide: Practical Fusion-Tag Workflow
2026-09-07
S Tag Peptide provides a compact, charged 15-amino-acid sequence for recombinant protein detection and protein solubility improvement when genetically fused to a target protein. This guide covers handling, construct design, QC, and troubleshooting, while clarifying that the free peptide is not a substitute for a validated recombinant fusion construct or antibody-based capture system.
Niclosamide Workflows for STAT3 Cancer Research
2026-09-05
Niclosamide enables a practical, multi-readout strategy for studying STAT3 Tyr-705 phosphorylation, proliferation, apoptosis, and NF-κB signaling in cancer models. This guide combines product-specific handling with disciplined concentration–response design and assay lessons adapted cautiously from a recent molluscicide study.
CFDA SE Cell Tracer Kit: Practical Guide
2026-09-04
The CFDA SE Cell Tracer Kit provides persistent fluorescent labeling for multi-day cell tracking, cell proliferation studies, and cell lineage tracing. It is appropriate for covalent live-cell marking but should not be selected for reversible labels, real-time physiological monitoring, or experiments that require an unvalidated universal staining concentration.
Saquinavir: From Protease Target to Assay Design
2026-09-04
Saquinavir is a valuable HIV protease inhibitor for linking antiviral mechanism with membrane-aware assay design. This article translates comparative IAM-LC and LEKC findings into practical decisions for antiretroviral drug research, HIV infection research, and translational workflows.
BKT140 (BL-8040) CXCR4 Assay Workflows
2026-09-03
Build more informative CXCR4 experiments with BKT140, from chemotaxis and apoptosis readouts to hematopoietic stem cell mobilization. This workflow-focused guide connects functional antagonist assays with receptor-aware oncology models and emerging CXCR4 theranostic strategies.
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-09-03
The reference study identifies an LMO2/LDB1 protein complex as a functional regulator of acute myeloid leukemia cell proliferation and survival. By integrating gene perturbation, protein-interaction mapping, transcriptomics, chromatin profiling, and rescue experiments, it connects LDB1-dependent transcriptional control with apoptosis-related programs and highlights a potential leukemia-maintenance vulnerability.
AM251 Workflows for CB1 Receptor Research
2026-09-02
AM251 is a nanomolar CB1 receptor antagonist for separating CB1-dependent signaling from broader endocannabinoid effects. This practical guide translates pain-model findings into reproducible workflows for neuroscience research, metabolic studies, receptor pharmacology, and apoptosis assays.
Bispecific Antibodies for Orthopoxvirus Protection
2026-09-02
Zhao and colleagues mapped functional anti-M1R and anti-B6R monoclonal antibodies and used the most effective candidates to build antibody cocktails and bispecific formats. Their results identify a VH–CH1 switch-region-inserting design with strong protection in a vaccinia virus mouse model, while also defining important boundaries between binding, neutralization, and in vivo efficacy.
2-APB for Calcium Signaling: Workflow & Troubleshooting
2026-09-01
Build reproducible calcium-release, SOCE-inhibition, and cell-fate assays with 2-APB while accounting for its concentration-dependent channel effects. This practical guide translates an ER-Ca2+-calpain study into actionable workflows for calcium imaging, autophagy–apoptosis analysis, and oxidative stress-related cell injury research.
miR-24-3p, Sp1/PI3K, and Doxorubicin HF
2026-09-01
The reference study identifies miR-24-3p as a regulator of doxorubicin-induced heart failure through suppression of the Sp1/PI3K axis. Using complementary rat and H9c2 cardiomyocyte models, the authors connect this pathway to cardiac dysfunction, apoptosis, and oxidative stress, while showing that miR-24-3p silencing is protective.
Mithramycin A in Transcriptional Mechanism Studies
2026-08-31
Mithramycin A is an anticancer antibiotic that turns G-C-rich DNA recognition into a powerful transcriptional perturbation tool. This article develops a mechanism-aware assay framework linking its cancer biology applications with the miR-24-3p/Sp1/PI3K findings in doxorubicin-induced cardiac injury.
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-08-31
Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from iron-dependent lipid peroxidation and promotes tumor progression. The study links m6A-dependent RNA regulation to iron sequestration, providing a mechanistic framework for evaluating ferroptosis sensitization in HCC models.
3770 records 8/252 page Previous Next First page 上5页 678910 下5页 Last page